Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice.

Autor: Åstrand A; Respiratory, Inflammation and Autoimmunity Innovative Medicines Research Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Wingren C; Respiratory, Inflammation and Autoimmunity Innovative Medicines Research Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Benjamin A; Institute for Infection and Immunity, St George's, University of London, London, UK., Tregoning JS; Mucosal Infection & Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London, UK., Garnett JP; Institute for Infection and Immunity, St George's, University of London, London, UK., Groves H; Mucosal Infection & Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London, UK., Gill S; Mucosal Infection & Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London, UK., Orogo-Wenn M; Institute for Infection and Immunity, St George's, University of London, London, UK., Lundqvist AJ; Respiratory, Inflammation and Autoimmunity Innovative Medicines Research Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Walters D; Institute for Infection and Immunity, St George's, University of London, London, UK., Smith DM; Cardiovascular & Metabolic Diseases Innovative Medicines Research Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Taylor JD; Respiratory, Inflammation and Autoimmunity Innovative Medicines Research Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Baker EH; Institute for Infection and Immunity, St George's, University of London, London, UK., Baines DL; Institute for Infection and Immunity, St George's, University of London, London, UK.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2017 May; Vol. 174 (9), pp. 836-847. Date of Electronic Publication: 2017 Mar 09.

Acarbose reduces Pseudomonas aeruginosa respiratory tract infection in type 2 diabetic mice.

Autor: Liu, Lin^1,2,3 (AUTHOR), Fan, Haiyang^1,2,3 (AUTHOR), Li, Liang^2,3 (AUTHOR) lil@sustech.edu.cn, Fan, Yunping¹ (AUTHOR) zhfanyp@163.com

Publikováno v: Respiratory Research. 12/14/2023, Vol. 24 Issue 1, p1-19. 19p.

Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study.

Autor: Jeong, Han Eol^1,2 (AUTHOR), Park, Sohee¹ (AUTHOR), Noh, Yunha^1,2 (AUTHOR), Bea, Sungho¹ (AUTHOR), Filion, Kristian B.^3,4 (AUTHOR), Yu, Oriana H. Y.^4,5 (AUTHOR), Jang, Seung Hun⁶ (AUTHOR), Cho, Young Min^7,8,9,10 (AUTHOR), Yon, Dong Keon^11,12 (AUTHOR), Shin, Ju-Young^1,2,13 (AUTHOR) shin.jy@skku.edu

Publikováno v: BMC Medicine. 2/10/2023, Vol. 21 Issue 1, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adverse effects of methylmercury on gut bacteria and accelerated accumulation of mercury in organs due to disruption of gut microbiota.

Autor: Natsumi Seki^1,2, Masahiro Akiyama^1,3 akiyama.masahiro@keio.jp, Hiroto Yamakawa³, Koji Hase^1,2, Yoshito Kumagai³, Yun-Gi Kim¹ ykim@keio.jp

Publikováno v: Journal of Toxicological Sciences. 2021, Vol. 46 Issue 2, p91-97. 7p.